Sort
130,381 grants matching “hiv”
Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic Vaccination
$1,510,625Dan H. Barouch · Beth Israel Deaconess Medical Center · P01 · FY2024 · AI
Model Development, Data Analysis, and Simulation for Affinity Maturation
$1,510,588Thomas B Kepler · Boston University Medical Campus · U19 · FY2018 · AI
Duke University Center for Translational Research
$1,510,568Duke University · P30 · FY2004 · AI
Neurokinin-1R (SP Receptor) Antagonists for HIV Therapy
$1,510,555Childrens Hospital Of Philadelphia · P01 · FY2005 · MH
PS10-1033, Kenya: INCREASING ACCESS TO QUALITY COMPREHENSIVE HIV PREVENTION SERVICES
$1,510,535Grace Muthumbi · International Medical Corps · U2G · FY2016 · PS
A pragmatic trial of two strategies for implementing an effective eHealth HIV prevention program
$1,510,118Brian Mustanski · Northwestern University At Chicago · R01 · FY2021 · MH
UCLA Los Angeles Brazil AIDS Consortium
$1,510,080Yvonne J Bryson · University Of California Los Angeles · UM1 · FY2012 · AI
Penn mental health AIDS research center
$1,510,062Dwight L. Evans · University Of Pennsylvania · P30 · FY2020 · MH
Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center
$1,510,020Kenneth B. Schechtman · Washington University · U24 · FY2020 · HL
INCREASING ACCESS TO AND UPTAKE OF HIV PREVENTION, CONFIDENTIAL VOLUNTARY COUNSEL
$1,509,999Harintsoa Lalah Rambeloson · Population Services International · U2G · FY2014 · PS
Ad26 Based Therapeutic Vaccines for HIV
$1,509,907Dan H. Barouch · Beth Israel Deaconess Medical Center · U01 · FY2020 · AI
CNS & Peripheral Viral Reservoirs/SIV Model of HIV HAART
$1,509,354Janice Ellen Clements · Johns Hopkins University · P01 · FY2013 · MH
HIV Persistence During Suppressive Antiretroviral Therapy
$1,509,286Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Molecular Biology Of Retroviruses Associated With AIDS
$1,509,083Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
PS09-991, IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION, CARE AND TREATMENT
$1,509,059Dr. Meshack Wanjuki · African Medical And Research Foundation · U2G · FY2016 · PS
REDUCE THE IMPACT OF HIV IN SO SUDAN, UNDER PRES EMERG PLAN F/AIDS RELIEF
$1,508,885Maureen Corbett · Intrahealth International, Inc. · U62 · FY2007 · PS
Drug, microbiome, and immune determinants of birth and neurodevelopmental outcomes in children with exposure to HIV infection
$1,508,882Grace C John-Stewart · University Of Washington · P01 · FY2025 · HD
PS10-1001, HIV PREVENTION PROJECTS
$1,508,586Mollie J Rosier · Alaska State Department Of Hlth-Soc Svcs · U62 · FY2010 · PS
Integrating HIV Prevention into Clinical Care for PLWHA in South Africa
$1,508,086Jeffrey D Fisher · University Of Connecticut Storrs · R01 · FY2010 · MH
PARTNERS/FENWAY/SHATTUCK CENTER FOR AIDS RESEARCH
$1,507,853Harvard University (Medical School) · P30 · FY2003 · AI
Oral pathogenesis and host interactions of KSHV infection (P01 Parent Level)
$1,507,828Timothy M Rose · Seattle Children'S Hospital · P01 · FY2011 · DE
COMBINATION PREVENTION OF HIV IN NW PROVINCE OF S. AFRICA SCALING BEST PRACTICE
$1,507,822Susan Jane Goldstein · Soul City · U2G · FY2013 · GH
Alabama Clinical Trials Unit
$1,507,599Michael S. Saag · University Of Alabama At Birmingham · UM1 · FY2015 · AI
Revealing Reservoirs during Rebound (R3)
$1,507,338David Mitchell Smith · University Of California, San Diego · P01 · FY2018 · AI
Positive Health Check Evaluation Trial
$1,506,717Megan A Lewis · Research Triangle Institute · U18 · FY2017 · PS